OTCMKTS:GLAPF

Glanbia Stock Forecast, Price & News

$14.75
0.00 (0.00 %)
(As of 04/22/2021 12:00 AM ET)
Add
Compare
Today's Range
$14.75
Now: $14.75
$14.75
50-Day Range
$12.40
MA: $13.76
$14.75
52-Week Range
$9.30
Now: $14.75
$14.75
Volume298 shs
Average Volume450 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Glanbia plc operates as a nutrition company. It operates through three segments: Glanbia Performance Nutrition, Glanbia Nutritionals, and Glanbia Ireland. The Glanbia Performance Nutrition segment manufactures and sells sports nutrition and lifestyle nutrition products in various formats, including powders, ready-to-eat bars and snacking foods, and ready-to-drink beverages through various channels, such as specialty retail, e-Commerce, and gyms, as well the food, drug, mass, and club channels. The Glanbia Nutritionals segment engages in the manufacture and sale of cheese, dairy and non-dairy nutritional and functional ingredients, and vitamin and mineral premixes. The Glanbia Ireland segment produces and sells a range of value added dairy ingredients and consumer products. This segment also sells animal nutrition and fertilizer products; and operates a chain of agricultural retail outlets in Ireland. The company also engages in the financing, research and development, property and land dealing, receivables management, management, property leasing, business service, and weight management solutions businesses. It provides its products under the Optimum Nutrition, SlimFast, BSN, Isopure, Nutramino, ABB, think!, Amazing Grass, and Body & Fit brands. The company has operations in North America, Europe, and internationally. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.
Glanbia logo

Industry, Sector and Symbol

Industry Packaged Foods
Sub-IndustryN/A
SectorN/A
Current SymbolOTCMKTS:GLAPF
CUSIPN/A
Phone353 56 777 2200
Employees7,632
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

Headlines

Glanbia Plc to Host Earnings Call
February 24, 2021 |  finance.yahoo.com
Glanbia lifts base milk price by 0.5c/L
January 12, 2021 |  msn.com
See More Headlines

MarketRank

Overall MarketRank

0.56 out of 5 stars

Packaged Foods Industry

18th out of 43 stocks

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$14.75
0.00 (0.00 %)
(As of 04/22/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GLAPF News and Ratings via Email

Sign-up to receive the latest news and ratings for GLAPF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Glanbia (OTCMKTS:GLAPF) Frequently Asked Questions

Is Glanbia a buy right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Glanbia in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Glanbia stock.
View analyst ratings for Glanbia
or view top-rated stocks.

What stocks does MarketBeat like better than Glanbia?

Wall Street analysts have given Glanbia a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Glanbia wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has Glanbia's stock price been impacted by COVID-19 (Coronavirus)?

Glanbia's stock was trading at $12.4079 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, GLAPF stock has increased by 18.9% and is now trading at $14.7485.
View which stocks have been most impacted by COVID-19
.

Who are Glanbia's key executives?

Glanbia's management team includes the following people:
  • Ms. Siobhán Talbot, Group MD & Exec. Director (Age 57)
  • Mr. Mark A. Garvey, Group Fin. Director & Exec. Director (Age 57)
  • Mr. Brian Phelan, Chief Exec. Officer of Glanbia Nutritionals (Age 54)
  • Mr. Hugh McGuire, Chief Exec. Officer of Glanbia Performance Nutrition (Age 50)
  • Mr. Liam Hennigan, Group Director of Strategic Planning & Investor Relations
  • Ms. Martha Kavanagh, Head of Corp. Communications
  • Mr. Tom Tench, Group Corp. Devel. Director (Age 50)
  • Mr. Michael Patten, Director of Group HR & Corp. Affairs (Age 59)
  • Mr. Michael Horan, Company Sec. (Age 56)
  • Mr. Jim Bergin, Chief Exec. of Glanbia Ingredients Ireland Limited (Age 58)

Who are some of Glanbia's key competitors?

What is Glanbia's stock symbol?

Glanbia trades on the OTCMKTS under the ticker symbol "GLAPF."

How do I buy shares of Glanbia?

Shares of GLAPF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Glanbia's stock price today?

One share of GLAPF stock can currently be purchased for approximately $14.75.

How many employees does Glanbia have?

Glanbia employs 7,632 workers across the globe.

What is Glanbia's official website?

The official website for Glanbia is www.glanbia.com.

How can I contact Glanbia?

The company can be reached via phone at 353 56 777 2200.


This page was last updated on 4/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.